SCHEMBL301932

SCHEMBL301932

CCNC1CCN(CCNC(=O)Nc2cc(C)nc(C)c2)CC1.O=S(=O)(O)c1cc(Cl)sc1Cl

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.37
MAPT P10636 4/20 0.36
TP53 P04637 2/20 0.36
UTS2R Q9UKP6 1/20 0.35
KMT2A Q03164 1/20 0.35
CACNA1H O95180 2/20 0.35
CYP2D6 P10635 2/20 0.35
KCNH2 Q12809 2/20 0.35
PKM P14618 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301930 0.86 CA1 (0.36) CNR1MAPTTP53UTS2RKMT2A
SCHEMBL3554952 0.85 KDM4E (0.43) CNR1MAPTTP53KMT2A
SCHEMBL3932204 0.84 CNR1 (0.37) CNR1MAPTTP53UTS2RCACNA1H
SCHEMBL3935356 0.82 MAPT (0.39) CNR1MAPTTP53UTS2RCACNA1H
SCHEMBL3557589 0.82 CNR1 (0.38) CNR1MAPTTP53UTS2RKMT2A
SCHEMBL301931 0.82 CACNA1H (0.40) CNR1MAPTTP53CACNA1HCYP2D6
SCHEMBL3556422 0.79 KDM4E (0.40) CNR1MAPTTP53UTS2RKMT2A
SCHEMBL301836 0.75 KDM4E (0.45) CNR1MAPTTP53UTS2RKMT2A
SCHEMBL3556286 0.75 KDM4E (0.45) CNR1MAPTTP53UTS2RKMT2A
SCHEMBL3941457 0.74 CNR1 (0.39) CNR1MAPTTP53UTS2RKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4851328-B2 2012-01-11 JP claimed
JP-2007506692-A 2007-03-22 JP claimed
EP-1670470-A1 PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2006-06-21 EP claimed
WO-2005030209-A1 PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2005-04-07 WO claimed